The global Gene Cell Therapy CDMO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Gene Cell Therapy CDMO Industry Forecast,” looks at past sales and reviews total world Gene Cell Therapy CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Cell Therapy CDMO sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Gene Cell Therapy CDMO landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue
• Market share
• Latest developments
• M&A activity

This report also analyses the strategies of leading global companies with a focus on Gene Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Cell Therapy CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Cell Therapy CDMO and breaks down the forecast by:

• Type
• Application
• Geography
• Market size

United States market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Gene Cell Therapy CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Gene Cell Therapy CDMO players cover:

• Catalent
• Lonza
• Thermo Fisher
• ACG Biologics
• Charles River

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Cell Therapy CDMO market by:

• Product type
• Application
• Key players
• Key regions and countries

Segmentation by Type:

• Immune Cells
• Stem Cell
• Viral Vector
• Plasmid DNA

Segmentation by Application:

• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutions
• Hospital
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and its market penetration:

• Catalent
• Lonza
• Thermo Fisher
• ACG Biologics
• Charles River
• Oxford Biomedica
• Novartis
• OBiO
• GenScript
• Pharmaron
• Porton